1. Home
  2. GFI vs TEVA Comparison

GFI vs TEVA Comparison

Compare GFI & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gold Fields Limited

GFI

Gold Fields Limited

HOLD

Current Price

$40.91

Market Cap

36.0B

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$36.58

Market Cap

40.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GFI
TEVA
Founded
1887
1901
Country
South Africa
Israel
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.0B
40.5B
IPO Year
2002
1996

Fundamental Metrics

Financial Performance
Metric
GFI
TEVA
Price
$40.91
$36.58
Analyst Decision
Buy
Strong Buy
Analyst Count
6
8
Target Price
$52.71
$38.63
AVG Volume (30 Days)
3.2M
5.4M
Earning Date
03-30-2026
04-29-2026
Dividend Yield
3.41%
N/A
EPS Growth
N/A
183.45
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$49.67
N/A
Revenue Next Year
N/A
$2.97
P/E Ratio
$25.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.24
$17.33
52 Week High
$61.52
$37.39

Technical Indicators

Market Signals
Indicator
GFI
TEVA
Relative Strength Index (RSI) 66.20 66.85
Support Level $38.14 $30.42
Resistance Level $41.27 $37.17
Average True Range (ATR) 1.09 0.95
MACD 0.63 0.25
Stochastic Oscillator 87.81 88.53

Price Performance

Historical Comparison
GFI
TEVA

About GFI Gold Fields Limited

Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia, and Peru. In Peru, the company also produces copper. The company is involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing, and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith, and South Deep, and surface-only open pit mining at Damang, Tarkwa, and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: